Amneal Pharmaceuticals, Inc.
AMRX
$10.48
$0.121.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 273.99% | 113.31% | 68.49% | -101.61% | -49.70% |
| Total Depreciation and Amortization | 8.17% | 8.34% | 16.15% | 3.07% | -2.69% |
| Total Amortization of Deferred Charges | -7.71% | 0.12% | 466.79% | -38.97% | 202.19% |
| Total Other Non-Cash Items | 7.91% | -6.11% | -70.85% | -17.31% | -27.22% |
| Change in Net Operating Assets | 38.10% | -788.42% | -59.30% | 223.12% | 52.90% |
| Cash from Operations | 111.36% | 267.98% | -13.06% | 74.20% | 449.55% |
| Capital Expenditure | -147.59% | -40.38% | -90.50% | -37.16% | 3.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.00% | 56.70% | 96.98% | -260.00% | 34.78% |
| Cash from Investing | -310.63% | 9.93% | 49.33% | -53.70% | 47.37% |
| Total Debt Issued | -- | 354.17% | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | 42.41% | -271.63% | 78.85% | -36.38% | -81.10% |
| Issuance of Common Stock | 91.34% | 146.43% | 251.16% | 51.23% | -- |
| Repurchase of Common Stock | -18.87% | -200.04% | -148.08% | -2.65% | -1,345.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -221.33% | 88.55% | 96.70% | 83.08% | 52.19% |
| Cash from Financing | -18.81% | -69.15% | 39.30% | -6.65% | -186.28% |
| Foreign Exchange rate Adjustments | -203.96% | -184.85% | -468.16% | 102.33% | 83.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 865.81% | -5.34% | 1,045.00% | 251.37% | 94.53% |